Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.42
WAT's Cash to Debt is ranked higher than
50% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.42 vs. WAT: 1.42 )
Ranked among companies with meaningful Cash to Debt only.
WAT' s 10-Year Cash to Debt Range
Min: 0   Max: 336.71
Current: 1.42

0
336.71
Equity to Asset 0.48
WAT's Equity to Asset is ranked lower than
67% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. WAT: 0.48 )
Ranked among companies with meaningful Equity to Asset only.
WAT' s 10-Year Equity to Asset Range
Min: -0.04   Max: 0.7
Current: 0.48

-0.04
0.7
Interest Coverage 15.15
WAT's Interest Coverage is ranked lower than
66% of the 103 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.06 vs. WAT: 15.15 )
Ranked among companies with meaningful Interest Coverage only.
WAT' s 10-Year Interest Coverage Range
Min: 2.74   Max: 9999.99
Current: 15.15

2.74
9999.99
F-Score: 7
Z-Score: 6.63
M-Score: -2.67
WACC vs ROIC
3.72%
37.13%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 27.19
WAT's Operating margin (%) is ranked higher than
93% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.85 vs. WAT: 27.19 )
Ranked among companies with meaningful Operating margin (%) only.
WAT' s 10-Year Operating margin (%) Range
Min: 8.08   Max: 28.55
Current: 27.19

8.08
28.55
Net-margin (%) 22.65
WAT's Net-margin (%) is ranked higher than
93% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. WAT: 22.65 )
Ranked among companies with meaningful Net-margin (%) only.
WAT' s 10-Year Net-margin (%) Range
Min: -1.78   Max: 25.03
Current: 22.65

-1.78
25.03
ROE (%) 24.69
WAT's ROE (%) is ranked higher than
93% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.27 vs. WAT: 24.69 )
Ranked among companies with meaningful ROE (%) only.
WAT' s 10-Year ROE (%) Range
Min: -12.26   Max: 68.79
Current: 24.69

-12.26
68.79
ROA (%) 12.11
WAT's ROA (%) is ranked higher than
85% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.87 vs. WAT: 12.11 )
Ranked among companies with meaningful ROA (%) only.
WAT' s 10-Year ROA (%) Range
Min: -1.81   Max: 22.73
Current: 12.11

-1.81
22.73
ROC (Joel Greenblatt) (%) 74.75
WAT's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.74 vs. WAT: 74.75 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WAT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 55.54   Max: 137.37
Current: 74.75

55.54
137.37
Revenue Growth (3Y)(%) 5.20
WAT's Revenue Growth (3Y)(%) is ranked higher than
54% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. WAT: 5.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WAT' s 10-Year Revenue Growth (3Y)(%) Range
Min: 5.2   Max: 17.8
Current: 5.2

5.2
17.8
EBITDA Growth (3Y)(%) 4.00
WAT's EBITDA Growth (3Y)(%) is ranked lower than
58% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. WAT: 4.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
WAT' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 2.4   Max: 69.7
Current: 4

2.4
69.7
EPS Growth (3Y)(%) 2.60
WAT's EPS Growth (3Y)(%) is ranked lower than
56% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.20 vs. WAT: 2.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WAT' s 10-Year EPS Growth (3Y)(%) Range
Min: 2.6   Max: 79.2
Current: 2.6

2.6
79.2
» WAT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

WAT Guru Trades in Q2 2014

Jeremy Grantham 176,039 sh (+30.97%)
Paul Tudor Jones 4,400 sh (+2.33%)
Pioneer Investments 21,592 sh (unchged)
Chuck Royce 13,250 sh (unchged)
John Hussman Sold Out
Ruane Cunniff 2,066,476 sh (-0.37%)
PRIMECAP Management 1,035,761 sh (-0.46%)
Jim Simons 18,800 sh (-84.46%)
» More
Q3 2014

WAT Guru Trades in Q3 2014

Ray Dalio 3,600 sh (New)
Joel Greenblatt 137,466 sh (New)
Jim Simons 289,500 sh (+1439.89%)
Paul Tudor Jones 5,568 sh (+26.55%)
Pioneer Investments 21,592 sh (unchged)
Chuck Royce 13,250 sh (unchged)
Ruane Cunniff 2,050,578 sh (-0.77%)
Jeremy Grantham 174,539 sh (-0.85%)
PRIMECAP Management 983,434 sh (-5.05%)
» More
Q4 2014

WAT Guru Trades in Q4 2014

Jim Simons 494,700 sh (+70.88%)
Chuck Royce 13,250 sh (unchged)
Ray Dalio Sold Out
Ruane Cunniff 2,049,064 sh (-0.07%)
PRIMECAP Management 975,734 sh (-0.78%)
Jeremy Grantham 164,415 sh (-5.80%)
Pioneer Investments 16,512 sh (-23.53%)
Paul Tudor Jones 3,600 sh (-35.34%)
Joel Greenblatt 56,395 sh (-58.98%)
» More
Q1 2015

WAT Guru Trades in Q1 2015

John Hussman 27,000 sh (New)
Chuck Royce 15,450 sh (+16.60%)
Ruane Cunniff 2,049,264 sh (+0.01%)
Paul Tudor Jones Sold Out
PRIMECAP Management 973,611 sh (-0.22%)
Jim Simons 415,100 sh (-16.09%)
Jeremy Grantham 137,415 sh (-16.42%)
Joel Greenblatt 46,450 sh (-17.63%)
Pioneer Investments 2,825 sh (-82.89%)
» More
» Details

Insider Trades

Latest Guru Trades with WAT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 24.80
WAT's P/E(ttm) is ranked higher than
62% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. WAT: 24.80 )
Ranked among companies with meaningful P/E(ttm) only.
WAT' s 10-Year P/E(ttm) Range
Min: 9.62   Max: 32.19
Current: 24.8

9.62
32.19
Forward P/E 21.19
WAT's Forward P/E is ranked lower than
55% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.28 vs. WAT: 21.19 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 24.70
WAT's PE(NRI) is ranked higher than
64% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.40 vs. WAT: 24.70 )
Ranked among companies with meaningful PE(NRI) only.
WAT' s 10-Year PE(NRI) Range
Min: 9.61   Max: 32.25
Current: 24.7

9.61
32.25
P/B 6.00
WAT's P/B is ranked lower than
112% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. WAT: 6.00 )
Ranked among companies with meaningful P/B only.
WAT' s 10-Year P/B Range
Min: 4.38   Max: 20.15
Current: 6

4.38
20.15
P/S 5.60
WAT's P/S is ranked lower than
123% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. WAT: 5.60 )
Ranked among companies with meaningful P/S only.
WAT' s 10-Year P/S Range
Min: 2.05   Max: 5.87
Current: 5.6

2.05
5.87
PFCF 25.30
WAT's PFCF is ranked lower than
54% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. WAT: 25.30 )
Ranked among companies with meaningful PFCF only.
WAT' s 10-Year PFCF Range
Min: 9.67   Max: 32.35
Current: 25.3

9.67
32.35
POCF 20.47
WAT's POCF is ranked lower than
61% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.50 vs. WAT: 20.47 )
Ranked among companies with meaningful POCF only.
WAT' s 10-Year POCF Range
Min: 7.83   Max: 25.37
Current: 20.47

7.83
25.37
EV-to-EBIT 18.94
WAT's EV-to-EBIT is ranked higher than
60% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.40 vs. WAT: 18.94 )
Ranked among companies with meaningful EV-to-EBIT only.
WAT' s 10-Year EV-to-EBIT Range
Min: 8.4   Max: 25.2
Current: 18.94

8.4
25.2
PEG 2.84
WAT's PEG is ranked higher than
53% of the 59 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.88 vs. WAT: 2.84 )
Ranked among companies with meaningful PEG only.
WAT' s 10-Year PEG Range
Min: 0.6   Max: 6.32
Current: 2.84

0.6
6.32
Shiller P/E 27.40
WAT's Shiller P/E is ranked lower than
53% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.32 vs. WAT: 27.40 )
Ranked among companies with meaningful Shiller P/E only.
WAT' s 10-Year Shiller P/E Range
Min: 13.57   Max: 44.59
Current: 27.4

13.57
44.59
Current Ratio 5.34
WAT's Current Ratio is ranked higher than
83% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. WAT: 5.34 )
Ranked among companies with meaningful Current Ratio only.
WAT' s 10-Year Current Ratio Range
Min: 1.19   Max: 5.34
Current: 5.34

1.19
5.34
Quick Ratio 4.86
WAT's Quick Ratio is ranked higher than
85% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. WAT: 4.86 )
Ranked among companies with meaningful Quick Ratio only.
WAT' s 10-Year Quick Ratio Range
Min: 0.74   Max: 4.86
Current: 4.86

0.74
4.86
Days Inventory 115.93
WAT's Days Inventory is ranked higher than
55% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 121.06 vs. WAT: 115.93 )
Ranked among companies with meaningful Days Inventory only.
WAT' s 10-Year Days Inventory Range
Min: 96.3   Max: 155.02
Current: 115.93

96.3
155.02
Days Sales Outstanding 71.29
WAT's Days Sales Outstanding is ranked lower than
65% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.58 vs. WAT: 71.29 )
Ranked among companies with meaningful Days Sales Outstanding only.
WAT' s 10-Year Days Sales Outstanding Range
Min: 67.61   Max: 89.8
Current: 71.29

67.61
89.8

Valuation & Return

vs
industry
vs
history
Price/Net Cash 114.00
WAT's Price/Net Cash is ranked lower than
147% of the 47 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.00 vs. WAT: 114.00 )
Ranked among companies with meaningful Price/Net Cash only.
WAT' s 10-Year Price/Net Cash Range
Min: 105.36   Max: 401.52
Current: 114

105.36
401.52
Price/Net Current Asset Value 21.50
WAT's Price/Net Current Asset Value is ranked lower than
110% of the 69 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. WAT: 21.50 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
WAT' s 10-Year Price/Net Current Asset Value Range
Min: 9.11   Max: 310.33
Current: 21.5

9.11
310.33
Price/Tangible Book 8.70
WAT's Price/Tangible Book is ranked lower than
103% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. WAT: 8.70 )
Ranked among companies with meaningful Price/Tangible Book only.
WAT' s 10-Year Price/Tangible Book Range
Min: 6.42   Max: 1313.3
Current: 8.7

6.42
1313.3
Price/DCF (Projected) 1.80
WAT's Price/DCF (Projected) is ranked lower than
75% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. WAT: 1.80 )
Ranked among companies with meaningful Price/DCF (Projected) only.
WAT' s 10-Year Price/DCF (Projected) Range
Min: 0.87   Max: 11.02
Current: 1.8

0.87
11.02
Price/Median PS Value 1.30
WAT's Price/Median PS Value is ranked lower than
74% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.00 vs. WAT: 1.30 )
Ranked among companies with meaningful Price/Median PS Value only.
WAT' s 10-Year Price/Median PS Value Range
Min: 0.14   Max: 3.56
Current: 1.3

0.14
3.56
Price/Peter Lynch Fair Value 3.40
WAT's Price/Peter Lynch Fair Value is ranked lower than
126% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. WAT: 3.40 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
WAT' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.68   Max: 5.59
Current: 3.4

0.68
5.59
Price/Graham Number 3.10
WAT's Price/Graham Number is ranked lower than
89% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. WAT: 3.10 )
Ranked among companies with meaningful Price/Graham Number only.
WAT' s 10-Year Price/Graham Number Range
Min: 2.3   Max: 20.36
Current: 3.1

2.3
20.36
Earnings Yield (Greenblatt) 5.30
WAT's Earnings Yield (Greenblatt) is ranked higher than
73% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. WAT: 5.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
WAT' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4   Max: 11.9
Current: 5.3

4
11.9
Forward Rate of Return (Yacktman) 10.62
WAT's Forward Rate of Return (Yacktman) is ranked lower than
51% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.90 vs. WAT: 10.62 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) only.
WAT' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 7.2   Max: 27.6
Current: 10.62

7.2
27.6

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:WAZ.Germany,
Waters Corp incorporated as a Delaware corporation in 1991, is an analytical instrument manufacturer, mainly designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography, ultra performance liquid chromatography and mass spectrometry instrument systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Waters became a publicly-traded company with its initial public offering ("IPO") in November 1995. The Company's two operating segments, Waters Division and TA Division, have similar economic characteristics; product processes; products and services; types and classes of customers; methods of distribution and regulatory environments. The Waters Division's products and services consist of high performance liquid chromatography ("HPLC"), ultra performance liquid chromatography ("UPLC" and together with HPLC, referred to as "LC"), mass spectrometry ("MS") and chemistry consumable products and related services. TA products and services consist of thermal analysis, rheometry and calorimetry instrument systems and service sales. The Company's products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic and governmental customers. These customers use the Company's products to detect, identify, monitor and measure the chemical, physical and biological composition of materials and to predict the suitability of fine chemicals, pharmaceuticals, water, polymers and viscous liquids in various industrial, consumer goods and healthcare products. The Company's competitors include: Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, Danaher Corporation and Thermo Fisher Scientific Inc. In the markets served by the TA Division, the Company's principal competitors include: PerkinElmer, Inc., Mettler-Toledo International Inc., NETZSCH-Geraetebau GmbH, Thermo Fisher Scientific Inc., Malvern Instruments Ltd., Anton-Paar and General Electric Company.
» More Articles for WAT

Headlines

Articles On GuruFocus.com
Weekly Insider Sells Highlight: WAT, KO, GILD, AZO, MAS Dec 14 2014 
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY Dec 08 2014 
Our Investment Strategy and Portfolio Selection Nov 09 2014 
Guru-Held Stocks Trading At Historical Low P/B Oct 08 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 27 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 19 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/B May 12 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 05 2014 

More From Other Websites
Waters Launches 5 Novel Mass Spectrometry Technologies - Analyst Blog May 28 2015
Waters Brings Novel Separations and Ionization Technologies to High Resolution Mass Spectrometry at... May 27 2015
Waters Brings Novel Separations and Ionization Technologies to High Resolution Mass Spectrometry at... May 27 2015
WATERS CORP /DE/ Financials May 16 2015
WATERS CORP /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 14 2015
10-Q for Waters Corp. May 11 2015
Waters Corporation Presentation at the UBS 2015 Global Healthcare Conference to Be Webcast Live May 11 2015
Waters Corporation Presentation at the UBS 2015 Global Healthcare Conference to Be Webcast Live May 11 2015
WATERS CORP /DE/ Files SEC form 10-Q, Quarterly Report May 08 2015
Waters Corporation Presentation at the Bank of America Merrill Lynch 2015 Health Care Conference to... May 06 2015
Waters Corporation Presentation at the Bank of America Merrill Lynch 2015 Health Care Conference to... May 06 2015
Waters Introduces eDATA 2.0 Proficiency Testing Portal for Environmental Laboratories May 04 2015
Waters Introduces eDATA 2.0 Proficiency Testing Portal for Environmental Laboratories May 04 2015
PerkinElmer Beats Q1 Earnings, Misses Revenue; Guides Up - Analyst Blog May 01 2015
Waters Corp (WAT) Earnings Report: Q1 2015 Conference Call Transcript Apr 28 2015
Stocks end mostly higher as company earnings reports pour in Apr 28 2015
Stocks end mostly higher as company earnings reports pour in Apr 28 2015
Waters Corp. Q1 Earnings Excel on High Product demand - Analyst Blog Apr 28 2015
Waters Corp Earnings Call scheduled for 8:30 am ET today Apr 28 2015
Waters Corp. (WAT) Tops Q1 Earnings and Revenues - Tale of the Tape Apr 28 2015
WATERS CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 28 2015
Waters tops Street 1Q forecasts Apr 28 2015
Waters tops Street 1Q forecasts Apr 28 2015
Q1 2015 Waters Corp Earnings Release - Before Market Open Apr 28 2015
Waters Reports First Quarter 2015 Financial Results Apr 28 2015
Will GoPro (GPRO) Keep the Earnings Streak Alive in Q1? - Analyst Blog Apr 27 2015
Will Parker-Hannifin (PH) Miss Earnings This Season? - Analyst Blog Apr 24 2015
Can Waters (WAT) Surprise on Q1 Earnings? - Analyst Blog Apr 24 2015
Waters UPLC I-Class/Xevo TQ-S System Approved for In Vitro Diagnostic Use in China Apr 14 2015
Waters Corporation Q1 2015 Financial Results Webcast Invitation Apr 06 2015
Waters Full Spectrum Molecular Imaging and ACQUITY UPLC System Each Recognized at Pittcon 2015 Mar 12 2015
Waters Highlights New Capabilities in Molecular Imaging, Laboratory Management and More at Pittcon... Mar 09 2015
Waters Corporation Presentation at the Cowen and Company 35th Annual Health Care Conference to Be... Mar 09 2015
Waters Corporation Presentation at the Leerink 2015 Global Healthcare Conference to Be Audio Webcast... Feb 05 2015
Waters beats Street 4Q forecasts Jan 26 2015
Waters tops Street 4Q forecasts Jan 26 2015
Waters Reports Fourth Quarter 2014 Financial Results Jan 26 2015
Waters Corporation Q4 2014 Financial Results Webcast Invitation – Now January 26, 2015 at 5:00 PM... Jan 26 2015
The Waters ionKey/MS Technology Named a Top Innovation for 2014 Jan 15 2015
Waters Corporation Q4 2014 Financial Results Webcast Invitation Jan 05 2015
Waters Corporation Presentation at the Stifel 2014 Healthcare Conference to Be Webcast Live Nov 11 2014
Waters PATROL UPLC Process Analysis System Receives Product Innovation Leadership Award from Frost &... Nov 11 2014
Waters Centers of Innovation Program Honors Colorado State University Laboratory Oct 28 2014
Waters Corp. tops Street 3rd-quarter forecasts Oct 21 2014
Waters Reports Third Quarter 2014 Financial Results Oct 21 2014
Waters Introduces Size Exclusion Chromatography (SEC) Columns for Protein-Based Biotherapeutics... Oct 15 2014
Nestle takes step towards customisable vitamins Jun 23 2014
Waters ACQUITY UPLC TQD System Receives Medical Device Approval in China Jun 05 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK